文献速递血栓与止血

巨核细胞生成过程中FLI1水平影响血小板生成与血小板生物学

FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.
PubMed 文献 · Blood · 2017-04-21

研究利用来自Paris-Trousseau综合征(PTSx)患者及靶向FLI1杂合敲除(FLI1+/-)对照系的诱导多能干细胞来源巨核细胞(iMegs),发现PTSx与FLI1+/- iMegs重现了巨核细胞/血小板减少等特征,且输注后释放的血小板半衰期短、功能差;FLI1缺陷iMegs中ETS1过表达,提示FLI1负调控ETS1;FLI1过表达则提高iMeg产量及体内释放血小板的产量、半衰期和功能。

要点

  • PTSx与FLI1+/- iMegs重现巨核细胞/血小板特征,iMeg产量及每个iMeg释放的血小板数减少。
  • 输注这些iMegs后体内释放的血小板半衰期短、功能差。
  • FLI1缺陷iMegs中ETS1过表达,提示FLI1在巨核细胞生成中负调控ETS1;FLI1过表达改善产量与功能。

核心结论

  • FLI1杂合性导致类似其他关键巨核细胞特异性转录因子的多效性缺陷,但不同于这些转录因子,FLI1过表达可改善产量和功能性。

研究设计与样本

  • 研究诱导多能干细胞(iPSC)来源巨核细胞(iMegs),包括来自PTSx患者的iPSC和靶向杂合FLI1敲除(FLI1+/-)对照系的iPSC。

主要发现

  • PTSx和FLI1+/- iMegs重现了许多已描述的巨核细胞/血小板特征,包括iMeg产量减少和每个iMeg释放的血小板减少。
  • 输注这些iMegs后体内释放的血小板半衰期短且功能差。
  • 在这些FLI1缺陷iMegs中,紧密连锁的ETS1过表达,提示FLI1在巨核细胞生成中负调控ETS1。
  • FLI1过表达增加未受损的体外iMeg产量,并增加体内释放血小板的产量、半衰期和功能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Friend leukemia virus integration 1 (FLI1), a critical transcription factor (TF) during megakaryocyte differentiation, is among genes hemizygously deleted in Jacobsen syndrome, resulting in a macrothrombocytopenia termed Paris-Trousseau syndrome (PTSx). Recently, heterozygote human FLI1 mutations have been ascribed to cause thrombocytopenia. We studied induced-pluripotent stem cell (iPSC)-derived megakaryocytes (iMegs) to better understand these clinical disorders, beginning with iPSCs generated from a patient with PTSx and iPSCs from a control line with a targeted heterozygous FLI1 knockout (FLI1+/-). PTSx and FLI1+/- iMegs replicate many of the described megakaryocyte/platelet features, including a decrease in iMeg yield and fewer platelets released per iMeg. Platelets released in vivo from infusion of these iMegs had poor half-lives and functionality. We noted that the closely linked E26 transformation-specific proto-oncogene 1 (ETS1) is overexpressed in these FLI1-deficient iMegs, suggesting FLI1 negatively regulates ETS1 in megakaryopoiesis. Finally, we examined whether FLI1 overexpression would affect megakaryopoiesis and thrombopoiesis. We found increased yield of noninjured, in vitro iMeg yield and increased in vivo yield, half-life, and functionality of released platelets. These studies confirm FLI1 heterozygosity results in pleiotropic defects similar to those noted with other critical megakaryocyte-specific TFs; however, unlike those TFs, FLI1 overexpression improved yield and functionality.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Vo KK, Jarocha DJ, Lyde RB, et al. FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology. Blood. 2017. PMID: 28432223. doi:10.1182/blood-2017-02-770958

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。